In 2594 patients with complete adverse event ( AE ) data , the incidence of grade 3 or greater 5FU-AEs in DPYD * 2A , I560S , and D949V carriers were 22/25 ( 88.0 % ) , 2/4 ( 50.0 % ) , and 22/27 ( 81.5 % ) , respectively .